Proactive investorsLogo Proactive Investors UK Website

Search field
Additional information
Additional Information
Market: TSX-V
Sector: Medical
Epic: TSX-V:TMD
News: Latest news
Web Site: Titan Medical Inc
Other Articles: 19-11-2008

RSS - Subscribe to the News Today on Proactive UK ▼

Thursday September 02, 11:00Baobab Resources identifies distinct ore domain at Tete’s South Zone

Baobab MD Ben James said the latest drilling results from the Tete project's South Zone characterise a distinct, higher mass recovery, ore domain.

FULL ARTICLE ►

RSS - Subscribe to the News Today on Proactive AU ▼

Thursday September 02, 08:15Indonesia edges closer toward uranium mining and nuclear power

After nearly five decades of national debate on the issue, Indonesia's central government may finally be ready to develop a national nuclear policy, which may lead to domestic uranium mining.

FULL ARTICLE ►

RSS - Subscribe to the News Today on Proactive CN ▼

Wednesday September 01, 01:25Green Dragon Gas reports significant growth as China’s thirst for energy continues

China's thirst for energy resources has continued with an increased focus on domestic supplies of gas, Green Dragon Gas chairman Randeep Grewal said today. In the company's interim results, [...]

FULL ARTICLE ►
Titan Medical Inc

Titan Medical Inc

Titan Medical focused on the development and commercialization of robotic surgical technologies. The Company is currently developing Amadeus(R), a next generation 4-armed robotic surgical system, with the objective of enabling surgeons to remotely manipulate surgical instruments.
Wednesday, November 19, 2008

Titan Medical in telesurgery collaboration with Bell Canada

by Andre Lamberti company news image

Titan Medical Inc has entered into a definitive agreement with Bell Canada's Health unit to develop, integrate and service telesurgery capabilities for Amadeus, a next generation robotic surgical system currently being developed to perform keyhole robotic minimally invasive surgery.


In February 2003, Bell was a major sponsor for the world's first hospital-to-hospital telerobotic surgery performed between North Bay and Hamilton.


Under the terms of the agreement, Bell Canada will make its IP-VPN bandwidth available to Titan Medical and Bell will be responsible for maintaining high level network performance and reliability necessary for real-time remote manipulation of Amadeus, Titan Medical said.


In addition, Bell will assist in the design, development and management of all aspects of telesurgery capabilities of Amadeus, including the integration of all connectivity software, cabling, end-to-end network management and engineering expertise.


Telesurgery is the ability for a surgeon to perform surgery on a patient from a different location and combines advanced elements of robotics, communication technologies and management information systems. Currently in the field of robotic surgery, most of robots are controlled by surgeons at the location of the surgery.


Titan Medical, listed in Toronto, focuses on the development and commercialization of robotic surgical technologies and is currently developing Amadeus, a next generation 4-armed robotic surgical system, with the objective of enabling surgeons to remotely manipulate surgical instruments.


The global robotic surgical market size is currently estimated to be CDN$3.4 billion with potential for placement of 6,000 robotic surgical systems, the company added.

AddThis Feed Button
Register here to be notified of future Titan Medical Inc articles.

Other Titan Medical Inc news

More news ►

Investors interested in Titan Medical Inc recently viewed


No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.